Method for synthesizing retinal, lycopene and phytoene
Genetic modifications to host cells with EMP and MEP pathways enhance retinal, lycopene, and phytoene synthesis, addressing cost and efficiency challenges in traditional methods, achieving high-purity and high-yield production using cost-effective raw materials and optimized culture conditions.
Patent Information
- Application Number
- PCT/JP2026/017441
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-07
- Filing Date
- 2026-05-06
- Publication Date
- 2026-11-12
AI Technical Summary
Current methods for synthesizing retinal, lycopene, and phytoene face challenges such as high energy consumption, complex purification processes, and the production of undesirable by-products, with retinal being difficult to purify from other retinoids and requiring expensive raw materials.
A method involving genetic modifications to host cells with the EMP and MEP pathways, enhancing specific enzyme gene expressions, and deleting or reducing the activity of certain genes to optimize retinal, lycopene, and phytoene synthesis, using cost-effective nitrogen sources like corn steep liquor and molasses, and employing two-phase culture with calcium carbonate.
Achieves high-purity and high-yield synthesis of retinal, lycopene, and phytoene, reducing production costs and environmental impact, with improved efficiency and purity compared to traditional methods.
Smart Images

Figure 00000059_0000 
Figure 00000059_0001 
Figure 00000059_0002
Abstract
Description
Method for synthesizing retinal, lycopene, and phytoene
[0001] This disclosure relates to a method for synthesizing retinal and a retinal-producing host. This disclosure also relates to a method for synthesizing lycopene and phytoene, and a phytoene-producing host. This application claims priority to Japanese Patent Application No. 2025-077658, as incorporated herein by reference.
[0002] (Retinal) Retinoids (vitamin A compounds, retinol, retinal, retinoic acid, etc.) are widely used in cosmetics and nutritional supplements. Traditionally, the production of retinoids by microorganisms has relied on expensive raw materials such as natural ingredients and refined sugars. Retinal is known to maintain healthy skin and mucous membranes and to suppress oxidation. Furthermore, retinal is biologically inactive and is converted to retinol under reducing conditions and to retinoic acid under oxidizing conditions. In addition, retinal is difficult to purify from other retinoids. For this reason, large-scale and high-purity synthesis of retinal is difficult.
[0003] Current chemical production methods for retinoids, including vitamin A and its precursors, have several undesirable characteristics, such as high energy consumption, complex purification processes, and / or undesirable by-products. Therefore, over the past several decades, approaches involving microbial conversion processes have been reported for producing retinoids, including vitamin A and its precursors, which may be more economical and ecological (see Patent Document 1).
[0004] (Substance production using microorganisms) In substance production technologies using microorganisms, attempts have been reported to improve the production efficiency of various target substances by using genetic engineering techniques to enhance the activity of metabolic enzymes or inactivate the activity of some metabolic enzymes in the metabolic systems involved in the production of the target substance (see Patent Document 2).
[0005] (Retinal Synthesis) As shown in Figure 15, several methods for synthesizing retinal have been reported. Patent Document 3 discloses a carotenoid-producing host cell comprising stereoselective beta-carotene oxidase (BCO), wherein the host cell produces a retinal mixture comprising cis- and trans-retinal, and the proportion of trans-retinal in the mixture produced by the host cell is at least about 65%, preferably 68, 70, 75, 80, 85, 90, 95, 98%, or up to 100%.
[0006] However, the above-mentioned literature differs from the retinal synthesis method and retinal-producing host described herein.
[0007] Japanese Patent Publication No. 2020-535795, Japanese Patent No. 7360741, Japanese Patent Publication No. 2020-535794
[0008] This disclosure aims to provide a method for synthesizing retinal. Furthermore, this disclosure aims to provide a method for synthesizing lycopene and phytoene.
[0009] To solve the above problems, the inventors confirmed that a host possessing the EMP pathway, MEP pathway, and carotenoid biosynthesis pathway can synthesize retinal by performing various genetic modifications on the host. Thus, the present invention completes the method for synthesizing retinal and the retinal-producing host. Furthermore, the inventors confirmed that a modified host with increased expression of a specific enzyme gene in the carotenoid biosynthesis pathway leading to retinal synthesis synthesizes lycopene with high efficiency, and that a modified host lacking the gene encoding phytoene desaturase (crtI gene) synthesizes phytoene. In addition, the inventors confirmed that high expression of the gene encoding polyprenyl diphosphate synthase (idsA gene) improved retinal production, high expression of the gene encoding the EIIBCFru component of the fructose-specific phosphotransferase system (ptsF gene) and the gene encoding fructokinase (fruK gene) improved fructose utilization, and suppressed β-carotene accumulation when corn steep liquor was used as a nitrogen source. Based on the above, the present inventors have completed the method for synthesizing lycopene, the method for synthesizing phytoene, and the phytoene-producing host described herein.
[0010] In other words, the present disclosure is as follows: 1. A method for synthesizing lycopene or retinal, the synthesis method comprising culturing a modified host having the EMP pathway, the MEP pathway and the carotenoid biosynthesis pathway, and having increased expression levels of a gene encoding at least one enzyme of the carotenoid biosynthesis pathway, in a culture medium, and recovering lycopene or retinal from the culture obtained by the culture. 2. The method according to item 1, wherein the modified host has or has a gene encoding lycopene cyclase and a gene encoding β-carotene 15,15'-dioxygenase, and the recovery is the recovery of retinal. 3. The method according to item 2, wherein the enzymatic activity of glyceraldehyde-3-phosphate dehydrogenase of the EMP pathway is reduced. 4. The method according to item 3, wherein a mutation is introduced into the start codon of the gene encoding glyceraldehyde-3-phosphate dehydrogenase. 5. 11. The method according to item 2, wherein the host gene encoding lycopene elongation enzyme (crtEb) is substantially deleted, absent, or non-functional. 6. The method according to item 2, wherein the host gene encoding a carotenoid biosynthesis regulator (crtR gene) is substantially deleted or absent. 7. The method according to item 2, wherein the host gene encoding GGPP synthase, the gene encoding phytoene synthase, and / or the gene encoding phytoene desaturase are introduced or the expression level of said genes is increased. 8. The method according to item 2, wherein the host gene encoding DXS, the gene encoding DXR, the gene encoding IspE, the gene encoding IspG, the gene encoding IspH, and / or the gene encoding Idi are introduced or the expression level of said genes is increased. 9. The method according to item 2, wherein the culture medium contains iron ions. 10. The method according to item 2, wherein the culture includes a two-phase culture step. 11. The method according to item 10, wherein the culture medium in the two-phase culture step contains an antioxidant. 12. The method according to item 10, wherein the culture temperature for the two-phase culture is 16 to 23°C. 13. The method according to item 2, wherein the culture includes a main culture step in which the culture is cultured in a medium containing molasses.14. The method according to item 13, wherein the culture medium containing molasses does not contain purified sucrose, biotin, and thiamine. 15. The method according to item 2, wherein the culture includes a main culture step of culturing in a medium containing corn steep liquor. 16. The method according to item 2, wherein the culture includes a main culture step of culturing in a medium containing molasses and corn steep liquor. 17. The method according to item 16, wherein the culture medium containing molasses and corn steep liquor does not contain purified sucrose, biotin, and thiamine. 18. The method according to item 2, wherein the host is a Corynebacterium. 19. The method according to item 2, wherein the enzymatic activity of glyceraldehyde-3-phosphate dehydrogenase in the EMP pathway is reduced, the gene encoding the host lycopene elongation enzyme is substantially deleted or absent, the gene encoding the host carotenoid biosynthesis regulator is substantially deleted or absent, the gene encoding the host GGPP synthase, the gene encoding phytoene synthase and / or phytoene desaturase is introduced or its expression level is increased, the gene encoding the host DXS, the gene encoding DXR, the gene encoding IspE, the gene encoding IspG, the gene encoding IspH and / or Idi is introduced or its expression level is increased. 20. The method according to item 2, wherein the gene encoding the host polyprenyl diphosphate synthase (idsA gene) is introduced or its expression level is increased. 21. The method according to item 2, wherein the gene encoding the EIIBCFru component of the host's fructose-specific phosphotransferase system (ptsF gene) and the gene encoding fructokinase (fruK gene) are introduced or the expression levels of said genes are increased. 22. The method according to item 21, wherein the culture comprises a main culture step of culturing in a medium containing molasses and corn steep liquor, and the β-carotene content in the recovered retinal is below the detection limit. 23. The method according to item 21, wherein the culture comprises a culture step using a jar fermenter.24. The method according to item 1, wherein the recovery is of lycopene, and the modified host does not have a gene encoding lycopene cyclase (crtY gene) introduced or is non-functional. 25. The method according to item 24, wherein the enzymatic activity of glyceraldehyde-3-phosphate dehydrogenase in the EMP pathway is reduced. 26. The method according to item 25, wherein a mutation is introduced in the start codon of the gene encoding glyceraldehyde-3-phosphate dehydrogenase. 27. The method according to item 24, wherein the host gene encoding lycopene elongation enzyme (crtEb) is substantially deleted, absent, or non-functional. 28. 31. The method according to item 24, wherein the host has been introduced with a gene encoding GGPP synthase, a gene encoding phytoene synthase and / or a gene encoding phytoene desaturase, or the expression level of said gene has been increased, and the host has been introduced with a gene encoding DXS, a gene encoding DXR, a gene encoding IspE, a gene encoding IspG, a gene encoding IspH and / or Idi, or the expression level of said gene has been increased. 29. The method according to item 24, wherein the host is a Corynebacterium. 30. A method for synthesizing phytoene, the method comprising culturing a modified host having the EMP pathway, the MEP pathway and the carotenoid biosynthesis pathway and substantially lacking or non-functional a gene encoding phytoene desaturase (crtI gene) in a culture medium, and recovering phytoene from the culture obtained by the culture. 31. The method according to item 30, wherein the culture medium contains calcium carbonate. 32. The method according to item 30, wherein the host is a Corynebacterium. 33. A retinal-producing host, the host having or having introduced genes encoding lycopene cyclase and β-carotene 15,15'-dioxygenase, and possessing the EMP pathway, MEP pathway and carotenoid biosynthesis pathway, and having reduced enzymatic activity of glyceraldehyde-3-phosphate dehydrogenase in the EMP pathway.34. The host described in paragraph 33, wherein a mutation has been introduced into the start codon of the gene encoding glyceraldehyde-3-phosphate dehydrogenase. 35. The host described in paragraph 33, wherein the gene encoding lycopene elongation enzyme is absent or substantially deleted. 36. The host described in paragraph 33, wherein the gene encoding a carotenoid biosynthesis regulator is substantially absent or deleted. 37. The host described in paragraph 33, wherein the gene encoding GGPP synthase, the gene encoding phytoene synthase, and / or the gene encoding phytoene desaturase has been introduced or the expression level of said gene has been increased. 38. The host described in paragraph 33, wherein the gene encoding DXS, the gene encoding DXR, the gene encoding IspE, the gene encoding IspG, the gene encoding IspH, and / or the gene encoding Idi has been introduced or the expression level of said gene has been increased. 39. The host described in paragraph 33, wherein the gene encoding polyprenyl diphosphate synthase (idsA gene) has been introduced or the expression level of said gene has been increased. 40. The host according to paragraph 33 or 39, wherein the gene encoding the EIIBCFru component of the host's fructose-specific phosphotransferase system (ptsF gene) and the gene encoding fructokinase (fruK gene) have been introduced or the expression levels of said genes have been increased. 41. A phytoene-producing host, wherein the host has the EMP pathway, the MEP pathway and the carotenoid biosynthesis pathway, and the gene encoding phytoene desaturase (crtI gene) is substantially deleted or non-functional.
[0011] This disclosure provides a method for synthesizing retinal and a retinal-producing host.
[0012] Plasmids used in the examples Plasmids used in the examples Plasmids used in the examples Plasmids used in the examples Plasmids used in the examples Plasmids used in the examples Method for creating gene knockout strains Method for creating promoter substitution strains Outline diagram for creating deletion strains of terminal enzyme genes and repressor genes of the carotenoid synthesis pathway Outline diagram for creating strains with increased expression of operons in the carotenoid synthesis pathway Outline diagram for creating strains that enhance the non-mevalonate pathway and regulate the metabolic flow rate of glycolysis Start codon substitution strains Schematic diagram of preparation of the modified strain. Schematic diagram of preparation of the modified strain with added retinoid synthesis pathway. Schematic diagram of the retinal biosynthesis pathway. Results of lycopene production in each modified strain. Schematic diagram of the culture and lycopene detection process of the modified strain. Results of β-carotene and retinal production (Example 3, left bar: β-carotene, right bar: retinal). (1) Culture method of β-carotene and retinal in the modified strain. (2) Results of retinal production with and without iron ion addition (Example 4, left bar: β-carotene, right bar: retinal). (1) Culture method of β-carotene and retinal in the modified strain. (2) Results of retinal production at each organic solvent addition timing (Example 5, left bar: β-carotene, right bar: retinal) (1) Culture method for β-carotene and retinal of modified strain, (2) Results of retinal production at each culture temperature (Example 6, left bar: β-carotene, right bar: retinal) Composition of BTM+sucrose / BTM+molasses culture medium (1) Culture method for β-carotene and retinal of modified strain, (2) Results of retinal production using molasses as a carbon source (Example 7, left bar: β-carotene, Right bar: Retinal) (1) Method for mass cultivation of β-carotene and retinal from modified strains, (2) Results of mass production of retinal (Example 8) Reported purity and production volume of retinal Composition of culture medium BTM+sucrose / BTM+molasses / CSL+molasses (1) Method for culturing β-carotene and retinal from modified strains, (2) Results of retinal production using molasses as the carbon source and corn steep liquor as the nitrogen source (Example 9, left bar: retinal, right bar: β-carotene) Biosynthetic pathways of Pantoea agglomerans and Pantoea ananatis Biosynthetic pathway of Rhodobacter capsulatus Biosynthetic pathway of Actinomycetospora OstreococcusModified biosynthetic pathway of lucimarinus Strain lineage of Corynebacterium glutamicum and schematic diagram of metabolic modifications in each strain Overall diagram of the metabolic pathway from sucrose to retinal in modified Corynebacterium glutamicum Schematic diagram of the culture protocol in Example 10 and composition of the synthetic medium (BTM+Suc medium) Results of retinal and β-carotene production of idsA gene high-expression strain and parent strain (Example 10, left bar: retinal, right bar: β-carotene) Composition of BTM+sucrose / BTM+molasses culture medium (substitution with molasses) (1) Results of retinal and β-carotene production of ptsF / fruK gene high-expression strain, idsA gene high-expression strain and parent strain (Example 11, left bar: retinal, right bar: β-carotene), (2) Amount of sugar remaining in the medium after 72 hours of culture Schematic diagram of the large-scale culture protocol using a jar fermenter in Example 11 (1 ) Time course of retinal and β-carotene production in jar fermenter culture (Example 11), (2) HPLC chromatogram of two-phase culture supernatant Literature comparison table of retinal production using various microorganisms Composition of BTM+sucrose / BTM+molasses / CSL+molasses culture medium Schematic diagram of the culture protocol in Example 12 Results of retinal and β-carotene production in each medium (BTM+Suc medium, BTM+Mol medium and CSL+Mol medium) (Example 12, left bar: retinal, right bar: β-carotene) Metabolic pathway diagram showing the principle of phytoene production by disruption of the crtI gene Schematic diagram of the phytoene extraction and analysis protocol in Example 13 Results of phytoene production of crtI gene knockout strain (Example 13, under conditions without CaCO3 addition and conditions with CaCO3 addition) Plasmid used in Example 10 (pK19mobsacB-Psod-idsA Plasmid used in Example 11 (mutation GTG to ATG): pK19mobsacB-TrrnB-Ptuf-fruK
[0013] This disclosure relates to a method for synthesizing retinal and a retinal-producing host. Furthermore, this disclosure relates to a method for synthesizing lycopene and phytoene, as well as a phytoene-producing host. The disclosure is described in detail below.
[0014] (Retinal-producing host) The retinal-producing host of this disclosure has the EMP pathway (glycolysis), the MEP pathway, and the carotenoid biosynthesis pathway, as shown in Figure 15. Furthermore, since the host has or has introduced the gene encoding lycopene cyclase (crtY) and the gene encoding β-carotene 15,15'-dioxygenase (blh), it also has a retinal synthesis pathway. Note that each pathway does not need to contain all genes or express all of them; it is sufficient that at least the genes necessary for or involved in retinal production are present or expressed. In addition, it has been confirmed that the retinal-producing host of this disclosure can achieve not only high retinal production but also high purity, as shown in the results of the following examples, by introducing, increasing (enhancing), decreasing (deleting) the expression levels of the various genes described below. Furthermore, it has been confirmed that the retinal-producing host of this disclosure can further improve retinal production by increasing the expression level of the gene encoding polyprenyl diphosphate synthase (idsA gene) (see Example 10, Figures 32 and 33), and / or increasing the expression levels of the gene encoding the EIIBCFru component of the fructose-specific phosphotransferase system (ptsF gene) and the gene encoding fructokinase (fruK gene) (see Example 11, Figure 32).
[0015] (Lycopene-producing host) The lycopene-producing host of this disclosure has the EMP pathway (glycolysis), the MEP pathway, and the carotenoid biosynthesis pathway. The lycopene-producing host of this disclosure is a host in which the gene encoding lycopene cyclase (crtY gene) has not been introduced or is non-functional. That is, the cyclization reaction from lycopene to β-carotene does not proceed in the carotenoid biosynthesis pathway, so lycopene accumulates (see Example 2, Figure 16). Similar to the retinal-producing host described above, the lycopene-producing host of this disclosure can achieve high lycopene production by applying various gene modifications described below (deletion of crtEb and crtR genes, increased expression levels of carotenoid synthesis pathway genes and MEP pathway genes, and decreased activity of gapA gene).
[0016] (Phytoene-producing host) The phytoene-producing host of this disclosure is a host that has the EMP pathway (glycolysis), the MEP pathway, and the carotenoid biosynthesis pathway, and in which the gene encoding phytoene desaturase (crtI gene) is substantially deleted or non-functional. That is, the dehydrogenation reaction from phytoene to lycopene does not proceed in the carotenoid biosynthesis pathway, so phytoene accumulates (see Example 13, Figure 44). Preferably, the amount of phytoene produced in the phytoene-producing host of this disclosure can be improved by including calcium carbonate in the culture medium (see Example 13, Figure 46).
[0017] (Host) The host of this disclosure is not particularly limited, as long as it has or has a gene encoding lycopene cyclase and a gene encoding β-carotene 15,15'-dioxygenase, as shown in Figure 15, and has the EMP pathway, MEP pathway and carotenoid biosynthesis pathway. Examples include Corynebacteria (in this embodiment), Pantoea (genus Pantoea) {Pantoea agglomerans (Figure 28), Pantoea ananatis (Figure 28)}, Rhodobacter capsulatus (Figure 29), Actinomycetospora (genus Actinomycetospora) (Figure 30), Ostreococcus lucimarinus (Figure 31), etc. In the case of lycopene-producing hosts, the introduction of the gene encoding lycopene cyclase (crtY gene) and the gene encoding β-carotene 15,15'-dioxygenase (blh gene) is not necessary; any host possessing the EMP pathway, MEP pathway, and carotenoid biosynthesis pathway can be used as described above. Furthermore, in the case of phytoene-producing hosts, it is necessary that the gene encoding phytoene desaturase (crtI gene) in the carotenoid biosynthesis pathway is substantially deleted or non-functional, and any host can be used as described above.
[0018] (Lycopene cyclase and β-carotene 15,15'-dioxygenase) As shown in Figure 15, the host of this disclosure has a reaction in which lycopene is cyclized to produce β-carotene in the presence of lycopene cyclase (CrtY). It also has a reaction in which β-carotene is reacted with an oxygen molecule at the central 15,15' position to produce retinal in the presence of β-carotene 15,15'-dioxygenase (Blh). The host of this disclosure can utilize genes encoding endogenous lycopene cyclase and genes encoding β-carotene 15,15'-dioxygenase, but if necessary, genes encoding lycopene cyclase and genes encoding β-carotene 15,15'-dioxygenase may be introduced into the host. The introduction method can be a known method. For example, it is possible to introduce a known plasmid containing the gene into the host. Furthermore, the gene encoding lycopene cyclase can be of any origin as long as it can carry out the above reaction. Examples include Pantoea ananatis, Rhodobacter sphaeroides, Deinococcus radiodurans, Micrococcus luteus, Rubrivivax gelatinosus, Paracoccus marcusii, Synechocystis sp. PCC 6803, and Flavobacterium johnsoniae. Additionally, the gene encoding β-carotene 15,15'-dioxygenase can be of any origin as long as it can carry out the above reaction.Examples include marine bacteria such as Pantoea ananatis, Deinococcus radiodurans, Micrococcus luteus, Sphingomonas paucimobilis, Agrobacterium aurantiacum, Paracoccus marcusii, Synechocystis sp. PCC 6803, and Flavobacterium johnsoniae. In the lycopene synthesis method, the gene encoding lycopene cyclase (crtY gene) and the gene encoding β-carotene 15,15'-dioxygenase (blh gene) are not introduced or are non-functional. As a result, lycopene accumulates as the final product in the carotenoid biosynthesis pathway (see Example 2, Figure 16).
[0019] (Glyceraldehyde-3-phosphate dehydrogenase) The hosts of this disclosure preferably have reduced activity of glyceraldehyde-3-phosphate dehydrogenase. Regarding the reduction in glyceraldehyde-3-phosphate dehydrogenase activity, the enzymatic activity of glyceraldehyde-3-phosphate dehydrogenase in these hosts may be exemplified as 0.95, 0.90, 0.80, 0.75, 0.70, 0.60, 0.50, 0.40, 0.30, 0.20, 0.10, 0.05, or 0.01 times or less compared to the enzymatic activity of wild-type glyceraldehyde-3-phosphate dehydrogenase. This reduction is due to the supply of a portion of glyceraldehyde-3-phosphate, a glycolysis intermediate, to the non-mevalonate pathway instead of pyruvate, thereby promoting the supply to carotenoid precursors. Methods for this reduction can utilize methods known to the present day. For example, this can be achieved by creating a mutant strain in which the start codon ATG of the gapA gene (locus_tag: NCgl1526) is replaced with GTG by a single nucleotide substitution using a two-step homologous recombination method (see Figure 12). Alternatively, this reduction can be achieved by replacing the start codon ATG of the gapA gene with TGT or by replacing it with a promoter weaker than the gapA promoter (wild-type promoter).
[0020] (Lycopene elongation enzyme) The host of this disclosure preferably has a substantially deleted or absent gene encoding lycopene elongation enzyme (crtEb: registered as NCgl0594 (locus_tag) in the genome of Corynebacterium glutamicum ATCC 13032 (GenBank accession number: BA000036.3)). In this disclosure, "substantially deleted or absent" means to an extent that does not affect retinal production of the host. The deletion method can be a method known to the present. For example, it can be achieved by creating a crtEb-deficient strain, which is the target gene, by two-step homologous recombination (see Figure 10). The deletion of the gene encoding lycopene elongation enzyme (crtEb gene) is preferably applied to both retinal-producing hosts and lycopene-producing hosts. In phytoene-producing hosts, the deletion of the crtEb gene is also preferred.
[0021] (Carotenoid Biosynthesis Regulators) The host of this disclosure preferably has a substantially deleted or absent gene encoding a carotenoid biosynthesis regulator (crtR gene). The crtR gene is registered as NCgl0601 (locus_tag) in the genome of Corynebacterium glutamicum ATCC 13032 (GenBank accession number: BA000036.3). The crtR gene encodes a MarR-type transcription regulator and represses transcription by binding to the promoter of the carotenoid synthesis operon (PcrtE) and its own gene promoter (PcrtR). Deletion of the crtR gene constitutively derepresses the expression of the carotenoid synthesis gene group. In this disclosure, "substantially deleted or absent" means to an extent that does not affect retinal production in the host. The deletion method can be a method known to the public. For example, this can be achieved by creating a crtR-deficient strain using a two-step homologous recombination method (see Figure 10).
[0022] (Carotenoid Synthesis Pathway) The host of this disclosure preferably has increased (enhanced) expression levels of the gene encoding GGPP synthase (crtE, locus_tag: NCgl0600), the gene encoding phytoene synthase (crtB, locus_tag: NCgl0598), and / or the gene encoding phytoene dehydrogenase (crtI, locus_tag: NCgl0597). Methods known to the extent of this increased (enhanced) expression level can be employed. For example, to increase the expression of the carotenoid synthesis gene group (crtE, crtB, crtI), this can be achieved by replacing the promoter upstream of these genes with a high-expression promoter (such as the tuf promoter). The tuf promoter is known as a high-expression promoter in Corynebacteria. For details, a strain in which the high-expression promoter has been replaced is prepared by a two-step homologous recombination method (see Figure 11). Furthermore, if the host of this disclosure lacks one or more of the genes encoding GGPP synthase (crtE), phytoene synthase (crtB), and phytoene dehydrogenase (crtI), these genes may be introduced into the host. The introduction method can employ known methods. For example, this can be achieved by introducing a plasmid containing these genes into the host. The origin of these genes is not particularly limited, but is preferably derived from a closely related species of the host. In contrast to the phytoene synthesis method, it is necessary that the gene encoding phytoene desaturase (crtI gene) is substantially deleted or non-functional. Deletion of the crtI gene blocks the conversion of phytoene to lycopene, leading to selective accumulation of phytoene (see Example 13, Figure 44). The deletion method can employ known methods. For example, this can be achieved by creating a crtI gene-deficient strain using a two-step homologous recombination method.
[0023] (Polyprenyl diphosphate synthase) The host of this disclosure is preferably introduced with a gene encoding polyprenyl diphosphate synthase (idsA gene) or with increased expression of said gene. The idsA gene encodes geranylgeranyl diphosphate (GGPP) synthase and catalyzes the condensation reaction from GPP to FPP to GGPP. High expression of the idsA gene enhances the supply of isoprenoid precursors to the carotenoid synthesis pathway and improves retinal production (see Example 10, Figures 32 and 35). The origin of the idsA gene is not particularly limited, but an example of the idsA gene from Corynebacterium glutamicum (ATCC 13032, GenBank: BA000036.3, locus_tag: NCgl2092) can be used. Methods known to the extent of expression can be employed. For example, this can be achieved by replacing the upstream promoter of the idsA gene with a high-expression promoter (such as the sod promoter or tuf promoter), and / or by mutating the start codon of the idsA gene from GTG to ATG to improve translation efficiency (see Figure 47).
[0024] (Enhanced Fructose Uptake and Utilization) The host of this disclosure is preferably introduced with a gene encoding the EIIBCFru component of a fructose-specific phosphotransferase system (PTS) (ptsF gene) and a gene encoding fructokinase (fruK gene), or with increased expression levels of said genes. In Corynebacterium glutamicum, the fruK gene and the ptsF gene constitute an operon in this order (GenBank: BA000036.3, fruK: locus_tag: NCgl1860, ptsF: locus_tag: NCgl1861), and the fruK gene and its downstream ptsF gene can be simultaneously expressed to a high expression level by replacing the upstream promoter of the fruK gene with a high expression promoter. The origin of the ptsF and fruK genes is not particularly limited, but examples include genes derived from Corynebacterium glutamicum (ATCC 13032, GenBank: BA000036.3, ptsF: locus_tag: NCgl1861, fruK: locus_tag: NCgl1860). Sucrose is hydrolyzed into glucose and fructose in the host. High expression of the ptsF and fruK genes promotes fructose uptake and phosphorylation, improving the efficiency of sugar utilization in the culture medium (see Example 11, Figure 37). Methods for increasing the expression levels can be known. For example, this can be achieved using a plasmid or genome insertion cassette in which the ptsF and fruK genes are placed under the control of a high-expression promoter.
[0025] (Non-mevalonate pathway) The host of this disclosure preferably contains the gene encoding DXS (1-deoxy-D-xylulose 5-phosphate synthase) (dxs, NCgl1827), the gene encoding DXR (1-deoxy-D-xylulose 5-phosphate reductoisomerase) (dxr, NCgl1940), the gene encoding IspD (2-C-methyl-D-erythritol 4-phosphate cytidyltransferase) (ispD, NCgl2570), the gene encoding IspE (4-diphosphocytidyl-2-C-methyl-D-erythritol kinase) (ispE, NCgl0874), the gene encoding IspF (2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase) (ispF, NCgl2569), and IspG (4-hydroxy-3-methylbut-2-enyl diphosphate The expression levels of the gene encoding synthase (ispG, NCgl1938), the gene encoding IspH (4-hydroxy-3-methylbut-2-enyl diphosphate reductase) (ispH, NCgl0982), and / or the gene encoding Idi (isopentenyl-diphosphate delta-isomerase) (idi, NCgl2223) are increased. Methods for increasing (enhancing) these expression levels can be known. For example, this can be achieved by replacing the upstream promoters of these genes with high-expression promoters (such as TUF promoters or SOD promoters). For details, strains with high-expression promoters are produced by a two-step homologous recombination method (see Figure 12). Furthermore, if one or more of these genes are absent in the host of this disclosure, these genes may be introduced into the host. Methods for this introduction can be known. For example, this can be achieved by introducing a plasmid containing these genes into the host. The origin of these genes is not particularly limited, but they are preferably derived from closely related species of the host.The NCgl numbers for each of the above genes are locus_tag numbers based on the genome of Corynebacterium glutamicum ATCC 13032 (GenBank accession number: BA000036.3, RefSeq accession number: NC_003450.3).
[0026] (Host culture method) The host culture method can employ methods that are already known. For example, the optimal culture conditions for the host can be used. For example, when using Corynebacterium as the host, it is preferable to use the optimal culture conditions for Corynebacterium. Typically, the culture process mainly includes plate cultivation, seed cultivation, and main cultivation. Furthermore, this culture process can be carried out not only using small-volume incubators such as flasks, but also using large-volume incubators such as jar fermenters (see Example 11, Figure 38). Cultivation using a jar fermenter allows for control of pH and stirring speed, enabling scaled-up production.
[0027] (Iron ions) The main culture step of the host culture method preferably includes iron ions as shown in the following examples (see Figure 19). The timing of iron ion addition is not particularly limited and may be at the start of the culture, during the culture, or both. The form of iron ion administration is iron ions (Fe) added to the culture medium. 2+ The available substances are not particularly limited as long as they can be supplied. For example, FeSO4, FeCl2, etc. are examples. The concentration is not particularly limited, but examples of concentrations in the culture medium of this culture include 0.1 mM to 5.0 mM, preferably 0.3 mM to 3.0 mM, and more preferably 0.5 mM to 1.0 mM.
[0028] (Two-phase culture) The main culture step of the host culture method preferably includes two-phase culture as shown in the following examples (see Figure 20). For example, the main culture step including two-phase culture can be achieved by performing the first main culture in a normal incubator (e.g., a flask), and then adding an organic solvent (an organic solvent that is immiscible with water, e.g., decane, dodecane, hexadecane, hexane) to the incubator to proceed to the two-phase culture (second main culture) step. Furthermore, if necessary, an organic solvent may be added to the incubator during the culture. For example, the timing of adding the organic solvent to form a two-phase culture is about 6 to 30 hours after the start of the main culture, preferably 8 to 28 hours, and more preferably 10 to 26 hours.
[0029] (Addition of calcium carbonate) The culture medium in the main culture step of this host culture method may preferably contain calcium carbonate (CaCO3). The addition of calcium carbonate suppresses the acidification of the medium by buffering the pH during culture, promoting host growth and the production of carotenoids. In particular, in the method of synthesizing phytoene, it has been confirmed that the amount of phytoene produced is significantly improved by using a medium to which calcium carbonate has been added (see Example 13, Figure 46).
[0030] The culture medium in the culture step of this host culture method preferably contains an antioxidant. The antioxidant can be any well-known antioxidant (such as dibutylhydroxytoluene (BHT), butylated hydroxyanisole (BHA), L-ascorbic acid, pyrogallic acid (pyrogallol), astaxanthin, or vitamin E (tocopherol)).
[0031] The optimal culture temperature for the culture step of this host culture method (especially for Corynebacterium-type bacterial hosts) is 16°C to 23°C, preferably 17°C to 22°C, more preferably 18°C to 21°C, and most preferably about 21°C. The above culture temperature range is particularly preferred for culturing retinal and lycopene-producing hosts. In the cultivation of phytoene-producing hosts, in addition to the above temperature range, a culture temperature of 25°C to 35°C, preferably 28°C to 32°C, and more preferably about 30°C can also be used (see Example 13).
[0032] (Cultivation using molasses) The culture medium for the main culture step of this host culture method can be made primarily from molasses, a concentrated liquid that is a by-product of sugar production and contains numerous organic and inorganic components, mainly sugars. When molasses is used, it is not necessary to add purified sucrose, biotin, and thiamine to the culture medium (see Figure 26). In addition, in the following examples, culture using a culture medium containing molasses as a carbon source yielded the same amount of retinal synthesis as culture using a culture medium containing purified sucrose, biotin, and thiamine. Furthermore, the detailed composition of the culture medium containing molasses (BTM+Mol medium) is shown in Figures 36 and 41. Molasses is a mixed sugar containing sucrose, glucose, and fructose, and due to the biotin, thiamine, and protocatechuic acid contained in molasses, it is not necessary to add these components separately to the culture medium (see Examples 11 and 12).
[0033] (Culturing using corn steep liquor) The culture medium for the main culture step of this host culture method can be made primarily from corn steep liquor, a by-product produced during corn milling. When corn steep liquor is used, it is not necessary to add a nitrogen source to the culture medium (see Figure 26). In addition, in the following examples, it was confirmed that culturing using a culture medium containing molasses as a carbon source and corn steep liquor as a nitrogen source did not result in the production of β-carotene and that the purity of retinal was very high. The detailed composition of the culture medium containing corn steep liquor and molasses (CSL+Mol medium) is shown in Figure 41. In CSL+Mol medium, corn steep liquor is used as the nitrogen source instead of synthetic nitrogen sources such as ammonium sulfate and urea in synthetic medium (BTM medium). In culturing using CSL+Mol medium, β-carotene production was below the detection limit and retinal production was improved compared to BTM+Suc medium and BTM+Mol medium (see Example 12, Figure 43). This confirms that it is possible to produce high-purity retinal using only inexpensive raw materials.
[0034] (Mass Production of Retinal) When culturing this host using a large-capacity incubator such as a jar fermenter and molasses as an inexpensive carbon source, large quantities of high-purity retinal can be produced. Furthermore, analysis of HPLC chromatograms confirmed that retinal was the main component of the retinoid composition in the two-phase culture supernatant, and that retinol and retinoic acid were not detected (see Figure 39). In addition, the amount of retinal produced using the modified Corynebacterium glutamicum disclosed herein was significantly higher than that reported using various microorganisms (Escherichia coli, Yarowia liporitica, budding yeast, etc.) (see Figure 40).
[0035] (Phytoene Production) In the method for synthesizing phytoene, a phytoene-producing host can be created by culturing a modified host in which the gene encoding phytoene desaturase (crtI gene) is substantially deleted or non-functional in a culture medium (see Example 13, Figure 44). Culturing of the phytoene-producing host can be carried out in a single-phase culture without two-phase culture. The culture medium preferably contains calcium carbonate, and the amount of phytoene produced is significantly increased by the addition of calcium carbonate (see Example 13, Figure 46).
[0036] (Method for recovering retinal using single-phase culture) When single-phase culture is used, a known method can be used to recover retinal. For example, the culture medium after culturing can be separated by centrifugation to remove the supernatant and obtain a cell pellet. The cell pellet can be soaked in an organic solvent such as acetone in an equal volume to the recovered culture medium, and then destroyed using a cell disruptor or the like. The mixture after destruction can then be separated by centrifugation to collect the supernatant, and retinal and other retinoid compounds can be recovered from the supernatant. The same single-phase extraction method can also be used to recover phytoene. For example, after obtaining a cell pellet by centrifugation of the culture medium after culturing, cell disruption can be performed using pyrogallol-containing acetone and zirconia beads, and the supernatant can be recovered by centrifugation to recover phytoene (see Example 13, Figure 45). In this disclosure, "culture" refers to the general term for the material obtained by culturing the modified host in the medium, and includes not only the material after the completion of culturing but also the material during culturing. Specifically, the culture comprises one or more of the following: the host (bacterial cells), the culture medium (culture solution including the culture supernatant), or the organic phase of an organic solvent added to the culture medium. In the method for synthesizing lycopene or retinal according to this disclosure, the recovery of lycopene or retinal can be carried out from the culture. For example, lycopene and phytoene can be recovered from the host (bacterial cells) after the completion of cultivation, and retinal can be recovered from the organic phase of an organic solvent added to the culture medium during or after cultivation (see Examples 5-12, Figures 20-24, 27, 39, and 43). The method for recovering retinal preferably includes recovery from the organic phase in two-phase culture (see Examples 5-12).
[0037] (Method for recovering retinal using two-phase culture) When using two-phase culture, known methods can be used to recover retinal. For example, since retinal is extracted into the organic phase, the culture medium can be separated into an aqueous phase and an organic phase by centrifugation during or after cultivation, and retinal and other retinoid compounds can be recovered from the organic phase. Similarly, when using two-phase culture, lycopene can be recovered by separating the culture medium into an aqueous phase and an organic phase by centrifugation after cultivation, and lycopene can be recovered from the organic phase.
[0038] Hereinafter, the present invention will be specifically illustrated by Examples, but the present disclosure is not limited to these Examples and the like.
[0039] (Bacterial strains used) In this Example, for the construction of modified bacteria having high retinal productivity, a coryneform bacterium (Corynebacterium glutamicum) was used as an example of a bacterium having a glycolytic pathway, a non-mevalonate pathway and a carotenoid synthesis system.
[0040] (Preparation of deletion strain of terminal enzyme gene in carotenoid synthesis pathway) In the carotenoid synthesis pathway, the endogenous crtEb gene (lycopene elongase gene) encoding an enzyme that metabolizes lycopene to extend it to flavoxanthin was disrupted. Specifically, according to the method described in Figure 8, using the plasmid pK19mobsacB-ΔcrtEb (reference: Figure 1) prepared based on the plasmid pK19mobsacB (reference: Figure 1), the target gene-deficient strain was prepared by a two-step homologous recombination method (reference: Figure 10).
[0041] (Preparation of carotenoid synthesis pathway repressor gene deletion strain) The crtR gene (carotenoid biosynthesis regulatory factor gene) encoding a transcriptional regulatory factor that represses the carotenoid synthesis operon was disrupted. Specifically, according to the method described in Figure 8, using pK19mobsacB-ΔcrtR (reference: Figure 2), the target gene-deficient strain was prepared by a two-step homologous recombination method (reference: Figure 10).
[0042] (Preparation of strain with enhanced expression of carotenoid synthesis pathway operon) In order to enhance the expression of the carotenoid synthesis gene cluster (crtE, crtB, crtI), the promoter upstream thereof was replaced with the tuf promoter. The tuf promoter is known as a high-expression promoter in coryneform bacteria. Specifically, according to the method described in Figure 9, using pK19mobsacB-Ptuf-crtE (reference: Figure 2), a strain in which the target gene was replaced was prepared by a two-step homologous recombination method (reference: Figure 11).
[0043] (Production of strain with enhanced non-mevalonate pathway) In order to improve the expression of the enzyme group of the MEP pathway involved in the synthesis of isoprenoid precursor (isopentenyl diphosphate (IPP)), the promoters of the enzyme genes were replaced with strong promoters (tuf promoter, sod promoter). Specifically, according to the method described in Figure 9, the upstream region of each gene of dxs (NCgl1827), dxr (NCgl1940), ispD (NCgl2570), ispE (NCgl0874, ispE operon), ispF (NCgl2569), ispG (NCgl1938), ispH (NCgl0982) and idi (NCgl2223), which are enzymes at each step of the non-mevalonate pathway, was replaced with a strong promoter by a two-step homologous recombination method using each plasmid (see: Figures 3-5) (see: Figure 12).
[0044] (Control of glycolytic metabolic flow rate) In order to optimize the supply of precursors from the glycolytic pathway to the non-mevalonate pathway, the expression level of glyceraldehyde-3-phosphate dehydrogenase (GapA) in the glycolytic pathway was reduced. Specifically, according to the method described in Figure 13, a mutant-introduced strain in which the start codon ATG of the gapA gene was subjected to 1-base substitution to GTG was produced by a two-step homologous recombination method using the plasmid pK19mobsacB-gapA mutation ATG to GTG (see: Figure 6) (see: Figure 12). Thereby, the translation efficiency of gapA (GapA) was reduced. By supplying a part of glyceraldehyde-3-phosphate, which is a glycolytic intermediate, to the non-mevalonate pathway instead of pyruvic acid, the supply of carotenoid precursors was further promoted. It should be noted that completely inactivating gapA would make the growth of the host itself difficult, so the translation efficiency was reduced as described above.
[0045] (Construction of the retinoid synthesis pathway) (1) Introduction of the β-carotene cyclase gene (lycopene β-cyclase) The enzyme gene crtY, which cyclizes lycopene to β-carotene, was introduced into the strain. Specifically, a strain into which the target gene was introduced was created using the plasmid pK19mobsacB-ldhAFR2-Ptuf-crtY (see Figure 6), which contains the crtY gene from Pantoea ananatis (see Figure 14). (2) Introduction of the β-carotene-15,15'-dioxygenase gene The enzyme gene blh, which cleaves β-carotene in the middle and produces retinal, was introduced into the strain. In detail, we created strains into which the target gene was introduced using two plasmids containing the blh gene (artificially synthesized gene encoding the protein corresponding to UniProt: Q4PNI0.1) derived from uncultured marine bacteria: pK19mobsacB-pqoFR-Ptuf-blh-rrnB and pK19mobsacB-Ncgl1660FR-Ptuf-blh-rrnB (see Figure 14).
[0046] (Modified bacteria with high retinal production capacity) Figure 15 shows a schematic of the retinal biosynthesis pathway in the modified strain C. glutamicum that has undergone the above genetic modification. Pyruvate and glyceraldehyde-3-phosphate (G3P) produced in glycolysis are converted to isoprenoid precursors (isopentenyl diphosphate: IPP and its isomer DMAPP) via the non-mevalonate pathway (MEP pathway), and then lycopene and subsequent carotenoids are synthesized via the carotenoid synthesis pathway. In this modified strain, the crtEb and crtR genes, indicated by the × marks in the figure, have been inactivated. On the other hand, in this modified strain, the expression of several enzyme groups, indicated by the arrows, has been enhanced to promote lycopene biosynthesis. In addition, the introduced foreign genes crtY and blh have added a new pathway for producing retinal from lycopene via β-carotene. In this modified strain, the biosynthesis of C50 carotenoids such as flavoxanthin and decaprenoxanthin, which are produced via the C. glutamicum-specific pathway, is substantially absent due to the deletion of the crtEb gene, and retinal is produced via C40 carotenoids. Furthermore, since C. glutamicum is thought to lack endogenous retinol dehydrogenase, the conversion of retinal to retinol and retinoic acid also substantially does not occur. In fact, the inventors have confirmed that this modified strain does not produce retinol or retinoic acid. As described above, the modified bacteria with retinal-producing ability of this disclosure have established a pathway specialized for retinal synthesis (see Figure 15).
[0047] (Selection of optimally high-expression genes in modified bacteria with high retinal production capacity) In this example, the deletion, substitution, and enhancement of optimal endogenous genes in modified bacteria were investigated using lycopene production as an indicator. ・Preparation of modified strains Ten modified strains were prepared according to the method described in Example 1, as shown in Figure 16. ・Culturing of modified strains and detection of lycopene (see Figure 17) (1) Plate culture Glycerol-stored strains were streaked onto BHI solid medium supplemented with 2% (w / v) glucose and cultured at 30°C for 24 hours. (2) Seed culture A single colony was selected from the obtained colonies and inoculated into 5 mL of BHI medium (37 g / L Brain-Heart Infusion, 20 g / L Sucrose), and cultured with shaking at 30°C and 180 rpm for 24 hours to obtain seed culture. (3) Flask culture (main culture) The above seed culture solution is inoculated into a flask containing 50 mL of BTM medium (2 g / L urea, 7 g / L ammonium sulfate, 0.5 g / L KH2PO4, 0.5 g / L K2HPO4, 0.5 g / L MgSO4・7H2O, 0.5 mg / L FeSO4・7H2O, 6 mg / L MnSO4・5H2O, 6 mg / L ZnSO4, 1 mg / L CuSO4・5H2O, 0.2 mg / L NiCl2・6H2O, 0.2 mg / L biotin, 0.2 mg / L thiamine hydrochloride, 3 mg / L protocatechuic acid and 20 g / L sucrose) and initial OD is performed. 600 The setting was changed to 0.2. Next, the cells were cultured at 30°C at 180 rpm for 72 hours. (4) Recovery of modified cells After the completion of culture, the modified cells were recovered by centrifugation (e.g., 13,000 rpm, 4°C, 5 min). (5) Extraction The recovered cells were destroyed and extracted with acetone, and the target compound (lycopene) was extracted using HPLC. (6) HPLC conditions Column: Inertsil ODS-3 Temperature: 45°C Mobile phase: Acetonitrile Flow rate: 1.2 mL / min Injection volume: 20 μL Detector: PDA
[0048] Figure 16 shows the lycopene production of each modified strain. It was confirmed that upregulation of the crt operon, dxs, idi, dxr, ispG, ispH, ispD, ispF, and ispE, as well as a gapA start codon mutation, improves lycopene production. In particular, a gapA start codon mutation significantly increases lycopene production. The following examples used strains with overexpression of the crt operon, dxs, idi, dxr, ispG, ispH, and ispE operons, as well as gapA start codon mutant strains. The modified strains used in these examples (strains before the introduction of the crtY and blh genes) can also be used as lycopene-producing hosts. The lycopene production observed in these examples indicates that modified hosts without the introduction or functioning of the crtY and blh genes possess the ability to synthesize lycopene.
[0049] (Investigation of optimal gene introduction for modified bacteria with retinal production ability) In this example, the optimal exogenous gene for the modified bacteria was selected using retinal production as an indicator. ・β-Carotene strain In the crt operon, dxs, idi, dxr, ispG, ispH, ispE operon overexpression and gapA start codon mutant strain of Example 2, the exogenous gene crtY was introduced. ・Retinal strain 1 In the crt operon, dxs, idi, dxr, ispG, ispH, ispE operon overexpression and gapA start codon mutant strain of Example 2, the exogenous gene crtY and plasmid pK19mobsacB-pqoFR-Ptuf-blh-rrnB containing the exogenous gene blh were introduced. Retinal strain 2 Overexpression of the crt operon, dxs, idi, dxr, ispG, ispH, and ispE operons, as well as gapA start codon mutant strains from Example 2, were introduced with plasmids pK19mobsacB-pqoFR-Ptuf-blh-rrnB containing the exogenous gene crtY and two types of exogenous genes blh, and plasmid pK19mobsacB-Ncgl1660FR-Ptuf-blh-rrnB containing the exogenous gene blh. Modified cells were cultured and harvested according to the method of Example 2. Furthermore, the harvested cells were extracted with acetone, and the target compounds (β-carotene and retinal) were extracted using HPLC.
[0050] Figure 18 shows the β-carotene and retinal production of each modified strain. For the β-carotene strain, 6.0 mg / L of β-carotene was produced. Retinal was not detected. For Retinal strain 1 (single blh introduction strain), 1.2 mg / L of retinal and 4.4 mg / L of β-carotene were produced. For Retinal strain 2 (double blh introduction strain), 0.8 mg / L of retinal and 3.1 mg / L of β-carotene were produced. It was confirmed that modified strains with the exogenous gene crtY and the exogenous gene blh could synthesize retinal. In subsequent examples, Retinal strain 2 (double blh introduction strain) was used.
[0051] (Effect of iron ion addition on increasing retinal production) It has been reported that Blh enzyme activity is promoted by iron ions (Kim YS et al., J. Biol. Chem., 2009, 284(23), 15781-15793). Therefore, we investigated whether retinal production could be improved by adding iron ions (FeSO4) to the culture medium of the modified strain.
[0052] ・Production of modified strains Following Example 2, mutant strains were produced with overexpression of the crt operon, dxs, idi, dxr, ispG, ispH, and ispE operons, gapA start codon mutations, and introduction of the exogenous gene crtY and the exogenous gene blh. ・Method for measuring β-carotene and retinal levels in modified strains (see Figure 19 (1)) (1) Culture medium and culture conditions The flask culture method of Example 2 was partially modified for cultivation. Medium to which FeSO4 was added to a final concentration of 1 mM, or medium to which FeSO4 was added to a final concentration of 0.5 mM at the start of culture and after 24 hours, respectively. Other culture conditions were the same as in Example 2. After the completion of culture, modified cells were collected by centrifugation (e.g., 10,000 rpm, 4°C, 10 min) and cell disruption was performed. (2) Measurement of β-carotene and retinal levels The amount of β-carotene and retinal was measured in the same manner as in Example 3. The acetone extract was collected and subjected to HPLC analysis.
[0053] Figure 19 shows the results of measuring β-carotene and retinal production with and without iron ion addition. The modified strain treated with a culture medium containing one dose of iron ions (1 mM FeSO4 single dose) showed a 32.5% increase in retinal production and a 24.8% decrease in β-carotene production compared to the modified strain treated with a culture medium without iron ions. The modified strain treated with a culture medium containing two doses of iron ions (0.5 mM FeSO4 double dose) showed a 42.2% increase in retinal production compared to the modified strain treated with a culture medium without iron ions. These results indicate that iron ion addition can promote retinal production.
[0054] (Effect of two-phase culture on increasing retinal production) Retinal is a lipid-soluble compound. In this example, we investigated whether two-phase culture, in which an organic solvent (containing an antioxidant) is added to the culture medium, can improve retinal production. Furthermore, we also investigated the effect of the timing of organic solvent addition on retinal production.
[0055] - Preparation of modified strains Similar to Example 4, overexpression of the crt operon, dxs, idi, dxr, ispG, ispH, and ispE operons, gapA start codon mutations, and exogenous gene crtY introduction and exogenous gene blh introduction mutant strains were used. - Measurement method of β-carotene and retinal content of modified strains (see Figure 20 (1)) Plate culture, seed culture, flask culture (first culture) and two-phase culture (second culture) were performed. Details of each culture are as follows: (1) Plate culture Glycerol-stored strains were streaked onto BHI solid medium supplemented with 2% (w / v) glucose and cultured at 30°C for 24 hours. (2) Seed culture A single colony was selected from the obtained colonies and inoculated into 5 mL of BHI liquid medium (37 g / L Brain-Heart Infusion, 20 g / L Sucrose), and cultured with shaking at 30°C and 180 rpm for 24 hours to obtain the seed culture medium. (3) Flask culture The above seed culture solution is inoculated into a flask containing 50 mL of BTM medium (2 g / L urea, 7 g / L ammonium sulfate, 0.5 g / L KH2PO4, 0.5 g / L K2HPO4, 0.5 g / L MgSO4・7H2O, 0.5 mg / L FeSO4・7H2O, 6 mg / L MnSO4・5H2O, 6 mg / L ZnSO4, 1 mg / L CuSO4・5H2O, 0.2 mg / L NiCl2・6H2O, 0.2 mg / L biotin, 0.2 mg / L thiamine hydrochloride, 3 mg / L protocatechuic acid and 20 g / L sucrose) and initial OD 600The ratio was set to 0.2. Next, 250 μL of 100 mM FeSO4・7H2O was added to the flask and incubated at 30°C at 180 rpm for 24 hours. (4) Two-phase culture Next, 5% n-dodecane containing 1% BHT and 250 μL of 100 mM FeSO4・7H2O were added to the flask so that the total concentration was 1 mM (0.5 mM iron ions were added in two separate additions (at 0 and 24 h)), and incubated at 30°C at 180 rpm for 72 hours. The timing of dodecane addition, which is an organic solvent, was carried out at the start of the flask culture time (0 h), 12 hours after incubation, 24 hours after incubation, 36 hours after incubation, or 48 hours after incubation. (5) Retinal recovery After the completion of incubation, the retinal in the organic phase was recovered by centrifugation (e.g., 10,000 rpm, 4°C, 10 min). (6) The amounts of β-carotene and retinal were the same as in Example 3. In particular, the organic phase of the two-phase culture was recovered and subjected to HPLC analysis. In the two-phase culture, β-carotene and retinal were calculated based on the volume of the organic phase.
[0056] Figure 20(2) shows the results of measuring the production of β-carotene and retinal by two-phase culture. Retinal production was significantly improved by two-phase culture (especially two-phase culture with antioxidant added), reaching over 70 mg / L and a maximum of 262.3 mg / L. In addition, it was confirmed that the timing for adding the organic solvent to form the two-phase culture was approximately 6 to 30 hours after the start of flask culture, preferably 8 to 28 hours, and more preferably 10 to 26 hours.
[0057] (Effect of increasing retinal production by optimizing the culture temperature in two-phase culture) Example 5 demonstrated that two-phase culture can increase retinal production compared to single-phase culture. In this example, the optimal culture temperature for two-phase culture was investigated.
[0058] - Preparation of modified strains Similar to Example 4, overexpression of the crt operon, dxs, idi, dxr, ispG, ispH, and ispE operons, gapA start codon mutations, and exogenous gene crtY and exogenous gene blh-introduced mutant strains were used. - Measurement method of β-carotene and retinal content of modified strains (see Figure 21 (1)) Plate culture, seed culture, flask culture, and two-phase culture were performed. Details of each culture are as follows: (1) Plate culture Glycerol-stored strains were streaked onto BHI solid medium supplemented with 2% (w / v) glucose and cultured at 30°C for 24 hours. (2) Seed culture A single colony was selected from the obtained colonies and inoculated into 5 mL of BHI liquid medium (37 g / L Brain-Heart Infusion, 20 g / L Sucrose), and cultured at 30°C and 180 rpm for 24 hours with overnight shaking to obtain the seed culture medium. (3) Flask culture The above seed culture solution is inoculated into a flask containing 50 mL of BTM medium (2 g / L urea, 7 g / L ammonium sulfate, 0.5 g / L KH2PO4, 0.5 g / L K2HPO4, 0.5 g / L MgSO4・7H2O, 0.5 mg / L FeSO4・7H2O, 6 mg / L MnSO4・5H2O, 6 mg / L ZnSO4, 1 mg / L CuSO4・5H2O, 0.2 mg / L NiCl2・6H2O, 0.2 mg / L biotin, 0.2 mg / L thiamine hydrochloride, 3 mg / L protocatechuic acid and 20 g / L sucrose) and initial OD 600The value was set to 0.2. Next, 250 μL of 100 mM FeSO4・7H2O was added to the flask immediately after the start of flask culture (after 0 hours), and cultured at 30°C at 180 rpm for 24 hours. The culture temperature was 15°C, 18°C, 21°C, 24°C, 27°C, 30°C, 33°C, or 36°C. (4) Two-phase culture Next, 5% n-dodecane containing 1% BHT and 250 μL of 100 mM FeSO4・7H2O were added to the flask, and the mixture was treated at 30°C at 180 rpm, followed by a further 48 hours of culture (72 hours in total). The culture temperature was 15°C, 18°C, 21°C, 24°C, 27°C, 30°C, 33°C, or 36°C. (5) After the completion of the retinal recovery culture, the retinal in the organic phase was recovered by centrifugation (e.g., 10,000 rpm, 4°C, 10 minutes). (6) Measurement of β-carotene and retinal amounts The same procedure as in Example 3 was followed. In particular, the organic phase of the two-phase culture was recovered and subjected to HPLC analysis. In the two-phase culture, β-carotene and retinal were calculated based on the volume of the organic phase.
[0059] Figure 21(2) shows the results of measuring β-carotene and retinal production at various culture temperatures using two-phase culture. It was confirmed that retinal production changed depending on the culture temperature of the two-phase culture (especially the two-phase culture with antioxidant added). Conventionally, the optimal growth temperature for Corynebacterium is known to be 30°C. However, contrary to conventional technical knowledge, it was confirmed that the optimal culture temperature is 16°C to 23°C, preferably 17°C to 22°C, more preferably 18°C to 21°C, and most preferably about 21°C.
[0060] (Retinal production using molasses as a carbon source) In this example, we investigated whether retinal could be produced in high yield by using molasses instead of purified sucrose as an inexpensive carbon source, and without adding expensive vitamins such as biotin or thiamine to the culture medium.
[0061] ・Processing of molasses A 50% (m / V) molasses solution was prepared by suspending commercially available molasses (manufacturer: EM Research Institute Co., Ltd.) in water. The molasses solution was centrifuged (6000 rpm, 10 min, 3 times) and sterilized by high temperature and pressure. The main components of molasses are sucrose, glucose, fructose, and other vitamins. ・Culture medium used The composition of Group 1: BTM + sucrose is shown in Figure 22. The composition of Group 2: BTM + molasses (without biotin and thiamine) is shown in Figure 22. ・Preparation of modified strains According to Example 2, strains with overexpression of crt operon, dxs, idi, dxr, ispG, ispH, and ispE operons, gapA start codon mutations, and exogenous gene crtY introduction and exogenous gene blh introduction mutants were used. • Culture medium and conditions (see Figure 23 (1)) Plate culture, seed culture, flask culture, and two-phase culture were performed. Details of each culture are as follows: (1) Plate culture Glycerol-stored strains were streaked onto BHI solid medium supplemented with 2% (w / v) glucose and cultured at 30°C for 24 hours. (2) Seed culture A single colony was selected from the obtained colonies and inoculated into 5 mL of BHI liquid medium (37 g / L Brain-Heart Infusion, 20 g / L Sucrose), and cultured at 30°C and 180 rpm for 24 hours with overnight shaking to obtain the seed culture solution. (3) Flask culture The above seed culture solution was inoculated into a flask containing 50 mL of BTM+sucrose (Group 1) or BTM+molasses (Group 2), and the initial OD was obtained. 600The value was set to 0.2. Next, 250 μL of 100 mM FeSO4・7H2O was added to the flask immediately after the start of flask culture (after 0 hours), and cultured at 21°C and 180 rpm for 24 hours. (4) Two-phase culture 5% n-dodecane containing 1% BHT and 250 μL of 100 mM FeSO4・7H2O were added to the flask, and cultured at 21°C and 180 rpm for a further 48 hours (72 hours in total). (5) Retinal recovery After the end of culture, retinal from the organic phase was recovered by centrifugation (e.g., 10,000 rpm, 4°C, 10 minutes). (6) Measurement of β-carotene and retinal amounts The same procedure as in Example 3 was followed. In particular, the organic phase of the two-phase culture was recovered and subjected to HPLC analysis. In the two-phase culture, β-carotene and retinal were calculated based on the volume of the organic phase.
[0062] Figure 23(2) shows the results of measuring the production of β-carotene and retinal using culture media containing molasses as a carbon source. Group 2, which used culture media containing molasses as a carbon source, showed a comparable amount of retinal synthesis (603.7 mg / L) compared to Group 1, which used culture media containing purified sucrose, biotin, and thiamine. Therefore, it was confirmed that the retinal synthesis method of this disclosure has lower production costs compared to conventional retinal synthesis methods using bacterial strains.
[0063] (Mass Production of Retinal) In this example, retinal production was carried out using a jar fermenter to evaluate whether retinal production by scaling up is commercially viable. Furthermore, retinal was produced using molasses as an inexpensive carbon source, and without adding expensive biotin or thiamine to the culture medium.
[0064] - Modified strain preparation Example 2: Overexpression of crt operon, dxs, idi, dxr, ispG, ispH, ispE operon, gapA start codon mutation, and exogenous gene crtY introduction and exogenous gene blh introduction mutant strains were used. - Culture medium and conditions (see Figure 24 (1)): Plate culture, seed culture, flask culture, and two-phase culture were performed. Details of each culture are as follows: (1) Plate culture: Glycerol-stored strains were streaked onto BHI solid medium supplemented with 2% (w / v) glucose and cultured at 30°C for 24 hours. (2) Seed culture: A single colony was selected from the obtained colonies, inoculated into 5 mL of BHI liquid medium (37 g / L Brain-Heart Infusion, 20 g / L Sucrose), and cultured at 30°C at 180 rpm for 24 hours with overnight shaking to obtain the seed culture medium. (3) Flask culture: The above seed culture solution is inoculated into a flask containing 50 mL of BTM+molasses (see Figure 22), and the initial OD is formed. 600 The value was set to 0.2. Next, 250 μL 100 mM FeSO4・7H2O was added to the flask after the start of flask culture (0 hours), and cultured at 21°C at 180 rpm for 24 hours. (4) Large-scale culture using a jar fermenter The flask culture solution was added to a jar fermenter (capacity 2.5 L, Able Co. product) and large-scale culture was performed. The culture solution was 1 L BTM + molasses medium, with an initial OD 600 (5) Two-phase culture 5% n-dodecane containing 1% BHT and 250 μL of 100 mM FeSO4・7H2O were added to a jar fermenter to a total concentration of 1 mM, and cultured at 30°C at 180 rpm for 60 hours. (6) Retinal recovery After the completion of culture, retinal from the organic phase was recovered by centrifugation (e.g., 10,000 rpm, 4°C, 10 min). (7) Measurement of retinal, retinol, and retinoic acid amounts The same procedure as in Example 3 was followed. In particular, the organic phase of the two-phase culture was recovered and subjected to HPLC analysis. In the two-phase culture, retinal was calculated based on the volume of the organic phase.
[0065] The results of measuring retinal production are shown in Figure 24(2). When large-scale culture was performed, the final concentration of retinal (96 hours from the start of jar fermenter culture) was 2260.1 mg / L (organic phase). Retinol and retinoic acid were not detected in this large-scale culture. The retinal synthesis method disclosed herein can produce large quantities of high-purity retinal (the ratio of retinal to the total amount of detected retinoid compounds (retinal, retinol, retinoic acid, etc.) is 99% or more) from a culture medium containing molasses, which is an inexpensive carbon source.
[0066] Figure 25 shows the reported purity and yield of retinal. The purity and total yield (mg / L) of retinal in this example were confirmed to be higher than those reported.
[0067] (Retinal production using molasses as a carbon source and corn steep liquor as a nitrogen source) In this example, we confirmed whether retinal could be produced in high yield using molasses as an inexpensive carbon source and corn steep liquor (CSL) as an inexpensive nitrogen source, without adding expensive biotin or thiamine to the culture medium. ・Processing of molasses Commercial molasses (manufacturer: EM Research Institute Co., Ltd.) was suspended in water to prepare a 50% (m / V) molasses solution. The molasses solution was centrifuged (6000 rpm 10 min 3 times) and sterilized by high temperature and pressure. ・Processing of corn steep liquor Commercial corn steep liquor (manufacturer: Oriental Yeast Co., Ltd.) was suspended in water, the pH was adjusted to 7.0, and then sterilized by high temperature and pressure. The main components of corn steep liquor are sugars, proteins, organic acids, and vitamins. It also contains amino acids such as leucine, glycine, and tyrosine. In addition, it contains lactic acid and phytic acid as organic acids. • Culture media used Group 1: The composition of BTM+sucrose is shown in Figure 26. Group 2: The composition of BTM+molasses (without Biotin and Thiamine) is shown in Figure 26. Group 3: The composition of CSL+molasses (without Biotin, Thiamine and ammonium sulfate) is shown in Figure 26. • Preparation of modified strains According to Example 2, strains with overexpression of crt operon, dxs, idi, dxr, ispG, ispH, and ispE operons, gapA start codon mutations, and exogenous gene crtY introduction and exogenous gene blh introduction mutants were used. • Culture media and culture conditions (see Figure 27 (1)) Plate culture, seed culture, flask culture and two-phase culture were performed. Details of each culture are as follows: (1) Plate culture Glycerol-stored strains were streaked onto BHI solid medium supplemented with 2% (w / v) glucose and cultured at 30°C for 24 hours. (2) Seed culture A single colony was selected from the colonies obtained and inoculated into 5 mL of BHI liquid medium (37 g / L Brain-Heart Infusion, 20 g / L Sucrose), and cultured at 30°C and 180 rpm for 24 hours with overnight shaking to obtain the seed culture medium.(3) Flask culture: Inoculate the above seed culture solution into a flask containing 50 mL of BTM+sucrose (Group 1), BTM+molasses (Group 2), or CSL+molasses (Group 3), and perform initial OD. 600 The value was set to 0.2. Next, 250 μL of 100 mM FeSO4・7H2O was added to the flask immediately after the start of flask culture (after 0 hours), and cultured at 30°C at 180 rpm for 24 hours. (4) Two-phase culture 5% n-dodecane containing 1% BHT and 250 μL of 100 mM FeSO4・7H2O were added to the flask, and cultured at 30°C at 180 rpm for a further 48 hours (72 hours in total). The 1% BHT was added 24 hours after the start of the two-phase culture. (5) Retinal recovery After the end of culture, the retinal in the organic phase was recovered by centrifugation (e.g., 10,000 rpm, 4°C, 10 minutes). (6) Measurement of β-carotene and retinal amounts The same procedure as in Example 3 was followed. In particular, the organic phase of the two phases was recovered and subjected to HPLC analysis. In two-phase culture, β-carotene and retinal were calculated based on the volume of the organic phase.
[0068] Figure 27(2) shows the results of measuring the β-carotene and retinal production of each group. Group 1, which used culture media containing purified sucrose, biotin, and thiamine, was able to obtain a high retinal production (623 mg / L). Group 2, which used culture media containing molasses as a carbon source, also showed a similar production amount of 585 mg / L. In addition, Group 3, which used molasses as a carbon source and CSL as a nitrogen source, produced 454 mg / L of retinal. Unexpectedly, the change in the nitrogen source resulted in no detectable β-carotene production (below the detection limit), and the purity of retinal was greatly improved. By using molasses and CSL, the external addition of vitamins (biotin and thiamine), urea, and ammonium sulfate became unnecessary, improving cost efficiency and allowing for the acquisition of high-purity retinal. As described above, the retinal synthesis method described herein, using molasses as the carbon source and corn steep liquor as the nitrogen source, has lower production costs, higher yields, and can produce higher purity retinal compared to conventional retinal synthesis methods using bacterial strains.
[0069] (Improvement of retinal production by high expression of the idsA gene) In this example, a modified strain was created in which the idsA gene, which encodes polyprenyl diphosphate synthase, was highly expressed in order to enhance the carbon flux to the carotenoid synthesis pathway and improve retinal production, and its effect was evaluated.
[0070] - Preparation of Modified Strains In a retinal-producing strain (hereinafter referred to as "YTKA747 strain") prepared according to the methods described in Examples 1 to 3, the expression of the idsA gene was enhanced. The idsA gene is an endogenous geranylgeranyl diphosphate synthase (polyprenyl diphosphate synthase) gene of Corynebacterium glutamicum (ATCC 13032, GenBank: BA000036.3, locus_tag: NCgl2092), and, like the crtE gene, catalyzes the condensation reaction from geranyl diphosphate (GPP) to geranylgeranyl diphosphate (GGPP) via farnesyl diphosphate (FPP) (see Figure 32). The aim was to enhance the carbon flux from isoprenoid precursors to the carotenoid synthesis pathway and improve retinal production by highly expressing the idsA gene. For details, a strain (hereinafter referred to as "YTKA777 strain") was created by using the plasmid pK19mobsacB-Psod-idsA mutation GTG to ATG (see Figure 47) and substituting the upstream region of the idsA gene with a high-expression promoter (sod promoter) using a two-step homologous recombination method, and by mutating the start codon of the idsA gene from GTG to ATG (see Figure 33). The substitution with the sod promoter increases the transcription level of the idsA gene, and the mutation of the start codon to ATG improves translation initiation efficiency, thereby enhancing the production of IdsA protein. Note that the method for high-expressing the idsA gene is not limited to the promoter substitution method and start codon mutation described above; methods such as introducing an expression cassette containing the idsA gene or using other high-expression promoters (such as the tuf promoter) can also be employed. The genotypes of YTKA747 strain and YTKA777 strain are summarized below.- YTKA747 strain: Overexpression of crt operon (Ptuf-crtE / crtB / crtI), dxs, idi, dxr, ispG, ispH, ispE operon, gapA start codon mutation (ATG→GTG), and exogenous gene crtY introduction and exogenous gene blh double transmutation (corresponding to Retinal strain 2 in Example 3). - YTKA777 strain: A strain of YTKA747 with the addition of high expression of the idsA gene (Psod-idsA, start codon GTG→ATG mutation).
[0071] - Culture medium and culture conditions Plate culture, seed culture, flask culture, and two-phase culture were performed. Details of each culture are as follows (see Figure 34). (1) Plate culture Glycerol-stored strains were streaked onto BHI solid medium supplemented with 2% (w / v) glucose and cultured at 30°C for 24 hours. (2) Seed culture A single colony was selected from the obtained colonies and inoculated into 5 mL of BHI liquid medium (37 g / L Brain-Heart Infusion, 20 g / L Sucrose), and cultured with shaking at 30°C and 180 rpm for 24 hours to obtain the seed culture solution. (3) Flask culture The above seed culture solution was inoculated into a flask containing 50 mL of BTM+molasses medium (see Example 7, Figure 22), and the initial OD600 was set to 0.2. Next, 250 μL of 100 mM FeSO4・7H2O was added to the flask immediately after the start of flask culture (after 0 hours), and the mixture was cultured at 21°C at 180 rpm for 24 hours. (4) Two-phase culture 5% n-dodecane containing 1% BHT and 250 μL of 100 mM FeSO4・7H2O were added to the flask, and the total concentration was adjusted to 1 mM (0.5 mM iron ions were added in two separate additions at 0 hours and 24 hours), and the mixture was cultured at 21°C at 180 rpm for a further 48 hours (72 hours in total). (5) Retinal recovery After the end of culture, the retinal in the organic phase was recovered by centrifugation (10,000 rpm, 4°C, 10 minutes). (6) Measurement of β-carotene and retinal amounts The same procedure as in Example 3 was followed. In particular, the organic phase of the two-phase culture was recovered and subjected to HPLC analysis. In two-phase culture, β-carotene and retinal were calculated based on the volume of the organic phase.
[0072] Figure 35 shows the results of measuring retinal and β-carotene production in an idsA gene-highly expressing strain (YTKA777) and the parent strain (YTKA747). Retinal production in the idsA gene-highly expressing strain (YTKA777) was increased by approximately 45% compared to that of the parent strain (YTKA747). On the other hand, no significant difference was observed in β-carotene production between the two strains. This result indicates that high expression of the idsA gene promotes the GPP→FPP→GGPP condensation reaction in cooperation with the crtE gene, thereby enhancing the carbon flux to the carotenoid synthesis pathway and improving retinal production. In subsequent examples, the idsA gene-highly expressing strain (YTKA777) was used.
[0073] (Improved fructose utilization by high expression of ptsF and fruK genes and mass production of retinal by jar fermenter) In this example, when using sucrose or molasses as a carbon source, modified strains were created with high expression of the ptsF and fruK genes, which are involved in fructose uptake and metabolism, in order to improve the utilization of fructose remaining in the culture medium and further increase retinal production, and the effects were evaluated. Furthermore, scale-up culture was carried out using a jar fermenter with these modified strains.
[0074] - In the modified strain (YTKA777 strain) described in Example 10, the expression of the ptsF and fruK genes was enhanced. The ptsF gene encodes the EIIBCFru component of the fructose-specific phosphotransferase system (PTS) and catalyzes the uptake of fructose into cells. The fruK gene encodes fructokinase (1-phosphofructokinase) and converts fructose-1-phosphate to fructose-1,6-bisphosphate (see Figure 32). On the genome of Corynebacterium glutamicum, the fruK gene (locus_tag: NCgl1860) and the ptsF gene (locus_tag: NCgl1861) constitute an operon in this order. In Corynebacterium glutamicum, when sucrose is used as a carbon source, sucrose is taken up by the phosphotransferase system (ptsS) and broken down into glucose-6-phosphate and fructose. Generally, glucose is consumed first, and fructose tends to accumulate in the culture medium. The aim was to enhance the uptake and utilization of fructose by overexpressing the ptsF and fruK genes, thereby enabling the simultaneous utilization of glucose and fructose. Specifically, using the plasmid pK19mobsacB-TrrnB-Ptuf-fruK (see Figure 48), a strain (hereinafter referred to as "YTKA813 strain") was created by replacing the upstream region of the fruK gene with a high-expression promoter (tuf promoter) and inserting the rrnB terminator (TrrnB) using a two-step homologous recombination method. Since the fruK and ptsF genes constitute an operon, replacing the upstream promoter of the fruK gene with the tuf promoter results in simultaneous high expression of both the fruK gene and its downstream ptsF gene. The rrnB terminator was inserted to prevent read-through transcription from the upstream gene and ensure transcription from the tuf promoter. Note that the method for high-expression of the ptsF and fruK genes is not limited to the promoter substitution method described above; other methods such as introducing an expression cassette containing each gene, or using other high-expression promoters (such as the sod promoter), can also be employed.The genotypes of strains YTKA747, YTKA777, and YTKA813 are summarized below. • YTKA747 strain: Overexpression of the crt operon (Ptuf-crtE / crtB / crtI), overexpression of dxs, idi, dxr, ispG, ispH, and ispE operons, gapA start codon mutation (ATG→GTG), and exogenous gene crtY introduction and exogenous gene blh double introduction mutant. • YTKA777 strain: YTKA747 strain with added high expression of the idsA gene (Psod-idsA, start codon GTG→ATG mutation). • YTKA813 strain: YTKA777 strain with added high expression of the fruK-ptsF operon (TrrnB-Ptuf-fruK / ptsF).
[0075] (1) Effect of high ptsF / fruK expression by flask culture ・Culture medium and culture conditions Plate culture, seed culture, flask culture (BTM + molasses medium, 21°C, 24 hours) and two-phase culture (5% n-dodecane with 1% BHT added, 21°C, 48 hours) were performed in the same manner as in Example 10. The details of the culture conditions were the same as in Example 10 (Figure 36). ・Measurement of retinal, β-carotene and residual sugar content of the modified strain The retinal and β-carotene content were measured in the same manner as in Example 10. Residual sugar content (sucrose, glucose and fructose) was measured by HPLC of the culture supernatant after 72 hours of culture. The HPLC conditions were as follows: Apparatus: Shimadzu Corporation, Column: Aminex HPX-87H column (300 mm × 7.8 mm, Bio-Rad), Mobile phase: Pure water, Flow rate: 0.6 mL / min, Column temperature: 30°C.
[0076] Figure 37 shows the results of measuring retinal and β-carotene production in flask culture strains with high expression of the ptsF and fruK genes (YTKA813 strain), a strain with high expression of the idsA gene (YTKA777 strain), and the parent strain (YTKA747 strain). High expression of the ptsF and fruK genes increased retinal production by approximately 1.4 times compared to the parent strain. Figure 37 shows the amount of sugar remaining in the culture medium after 72 hours of culture. The amount of sugar remaining was measured for the strain with high expression of the idsA gene (YTKA777 strain) and the strain with high expression of the ptsF / fruK genes (YTKA813 strain). In the strain with high expression of the idsA gene (YTKA777 strain), approximately 3.7 g / L of fructose remained, while in the strain with high expression of the ptsF / fruK genes (YTKA813 strain), the amount of fructose remaining decreased to approximately 0 g / L. These results indicate that high expression of the ptsF and fruK genes improved fructose utilization. This efficient utilization of fructose is thought to have increased the efficiency of carbon source utilization, contributing to a further improvement in retinal production.
[0077] (2) Large-scale culture using jar fermenter Furthermore, scale-up culture using a jar fermenter was performed using the YTKA813 strain. ・Medium and culture conditions (see: Figure 38) Plate culture, seed culture, flask culture, jar fermenter culture and two-phase culture were performed. Details of each culture are as follows. (1) Plate culture The glycerol stock strain was streaked onto a BHI solid medium supplemented with 2% (w / v) glucose, and cultured at 30°C for 24 hours. (2) Seed culture A single colony was selected from the obtained colonies, inoculated into 5 mL of BHI liquid medium (37 g / L Brain-Heart Infusion, 20 g / L sucrose), and shake-cultured at 30°C and 180 rpm for 24 hours to obtain a seed culture solution. (3) Flask culture The above seed culture solution was inoculated into a flask containing 50 mL of BTM+molasses medium, and the initial OD600 was set to 0.2. Culture was performed at 21°C and 180 rpm for 24 hours. (4) Jar fermenter culture The flask culture solution was added to a jar fermenter (2.5 L capacity, manufactured by Able Biott Co., Ltd.) for large-scale culture. The culture solution was 1 L of BTM+molasses medium, and the initial OD 600 was set to 1.0. The culture temperature was 21°C, and the stirring speed was 700 rpm. The pH was maintained at 7.0 using aqueous ammonia, and the culture was performed for 24 hours. (5) Two-phase culture 5% n-dodecane containing 1% BHT was added to the jar fermenter, and the culture was further performed in BTM+molasses medium at 21°C and 700 rpm for 60 hours. (6) Recovery of retinal After the completion of the culture, retinal in the organic phase was recovered by centrifugation (10,000 rpm, 4°C, 10 minutes). (7) Measurement of retinal amount, retinol amount and retinoic acid amount The procedure was the same as in Example 3. In particular, the organic phase of the two phases was collected and subjected to HPLC analysis.
[0078] Figure 39 shows the time course of retinal and β-carotene production from jar fermenter culture. Retinal production increased with the progression of culture time, and 96 hours after the start of jar fermenter culture, retinal production was 148.7 mg / L based on the volume of the aqueous phase and 2,974 mg / L based on the volume of the organic phase. β-carotene was detected at each time point, but the proportion of retinal among the produced carotenoids was extremely high. Furthermore, when the HPLC chromatogram was examined and compared with the peaks of the blank (culture medium only), retinoic acid standard, retinol standard, and retinal standard, only the retinal peak was detected from the organic phase of this culture medium, and other retinoid compounds such as retinol and retinoic acid were not detected (see Figure 39). This result further confirms that this modified strain produces high-purity retinal. Based on the above, it was confirmed that the ptsF / fruK gene-highly expressing strain (YTKA813 strain) can produce high-purity retinal at a concentration of 148.7 mg / L based on the volume of the aqueous phase (2,974 mg / L based on the volume of the organic phase) using molasses, an inexpensive carbon source, even in large-scale culture using a jar fermenter. This value surpasses the retinal production yield by previously reported Corynebacterium strains (104.9 mg / L based on the volume of the aqueous phase, Hao et al., Bioresour. Technol., 2026), achieving the highest value ever recorded for retinal production using Corynebacterium strains (see Figure 40). In subsequent examples, the ptsF / fruK gene-highly expressing strain (YTKA813 strain) was used.
[0079] (High-purity retinal production using corn steep liquor as a nitrogen source) In this example, the production of retinal and β-carotene was evaluated using corn steep liquor (CSL), an inexpensive nitrogen source, with a ptsF / fruK gene-high expression strain (YTKA813 strain). In Example 9, it was shown that β-carotene accumulation was below the detection limit when CSL was used as the nitrogen source. In this example, it was confirmed whether a similar effect could be obtained with the YTKA813 strain.
[0080] • Culture media used The following three types of culture media were used. Group 1: BTM+sucrose medium (synthetic medium) Composition: 2 g / L urea, 7 g / L ammonium sulfate, 0.5 g / L KH2PO4, 0.5 g / L K2HPO4, 0.5 g / L MgSO4・7H2O, 1 mL / L metal solution, 10 mg / L CaCl2・2H2O, 0.2 mg / L biotin, 0.2 mg / L thiamine, 0.2 mg / L protocatechuic acid, 20 g / L sucrose (see Figure 41) Group 2: BTM+molasses medium Composition: 2 g / L urea, 7 g / L ammonium sulfate, 0.5 g / L KH2PO4, 0.5 g / L K2HPO4, 0.5 g / L MgSO4・7H2O, 1 mL / L metal solution, 10 mg / L CaCl2・2H2O. Molasses (20 g / L as total sugar) was used instead of sucrose, and biotin, thiamine, and protocatechuic acid were not included (see Figure 41). Group 3: CSL+molasses medium composition: 20 g / L corn steep liquor (CSL), 0.5 g / L KH2PO4, 0.5 g / L K2HPO4, 0.5 g / L MgSO4・7H2O, 1 mL / L metal solution, 10 mg / L CaCl2・2H2O, molasses (20 g / L as total sugar). Urea, ammonium sulfate, biotin, thiamine, and protocatechuic acid were not included (see Figure 41). Molasses treatment and corn steep liquor treatment were carried out in the same manner as described in Examples 7 and 9, respectively. Medium and culture conditions Plate culture, seed culture, flask culture, and two-phase culture were performed. Culture conditions were the same as in Example 10 (see Figure 42). The measurement of β-carotene and retinal amounts was carried out in the same manner as in Example 10.
[0081] Figure 43 shows the retinal and β-carotene production amounts for each medium. The retinal production amount in the BTM+molasses medium (Group 2) was comparable to that of the synthetic medium containing purified sucrose (BTM+Suc medium). Notably, β-carotene accumulation in the CSL+molasses medium was below the detection limit. In other words, by using CSL as a nitrogen source, the accumulation of β-carotene, a byproduct, was eliminated, and higher purity retinal could be produced. This result is consistent with the result of Example 9 (β-carotene was below the detection limit in the CSL+molasses medium when using the YTKA747 strain), and it was confirmed that the β-carotene accumulation suppression effect by using CSL was reproduced in the YTKA813 strain as well. In summary, it was confirmed that by using CSL as a nitrogen source, the accumulation of β-carotene, a byproduct, can be eliminated, and higher purity retinal can be produced. CSL is an inexpensive nitrogen source, which is also advantageous in terms of cost.
[0082] (Preparation of phytoene-producing strain and phytoene production) In this example, a modified strain that produces phytoene, a white carotenoid, was prepared, and its phytoene production was evaluated. Phytoene is a white carotenoid with UV-absorbing properties and is expected to be used as a cosmetic ingredient (sunscreen, etc.).
[0083] - In the ptsF / fruK gene high-expression strain (YTKA813 strain) described in Example 11 of the preparation of modified strains, the crtI gene, which encodes phytoene desaturase, was disrupted. The crtI gene encodes an enzyme that catalyzes the desaturation reaction (desaturation) of phytoene to lycopene in the carotenoid synthesis pathway. By disrupting the crtI gene, the aim was to block the synthesis of lycopene, β-carotene, and retinal, which are downstream metabolites of phytoene, and to accumulate phytoene (see Figure 44). Specifically, a crtI gene-deficient strain (hereinafter referred to as "YTKA853 strain") was prepared by two-step homologous recombination using plasmid pK19mobsacB-ΔcrtI according to the method described in Figure 8.
[0084] - Culture medium and culture conditions Plate culture, seed culture, and flask culture were performed. Since phytoene is a carotenoid that accumulates in cells, two-phase culture was not performed in this example, and phytoene was produced by single-phase culture (see Figure 45). Details of each culture are as follows: (1) Plate culture Glycerol-stored strains were streaked onto BHI solid medium supplemented with 2% (w / v) glucose and cultured at 30°C for 24 hours. (2) Seed culture A single colony was selected from the obtained colonies and inoculated into 5 mL of BHI liquid medium (37 g / L Brain-Heart Infusion, 20 g / L Sucrose), and cultured with shaking at 30°C and 180 rpm for 18 hours to obtain seed culture solution. (3) Flask culture The above seed culture solution was inoculated into a flask containing 50 mL of BTM+sucrose medium (see Example 7, Figure 22). Two groups were established: a group without CaCO3 and a group with CaCO3. In the CaCO3 supplementation group, 1 mL of a 25% (w / v) CaCO3 suspension was added 6 hours after the start of culture. Culture was performed at 30°C and 180 rpm for 72 hours.
[0085] ・Phytoene Extraction Method After the culture was completed, 1 mL of the culture medium was sampled and the cell pellet was recovered by centrifugation (10,000 g, 5 min). To the recovered cell pellet, 1 mL of acetone containing 2 mg / mL pyrogallic acid and 0.1 g of zirconia beads were added. Pyrogallolic acid was added as an antioxidant to prevent oxidative degradation of carotenoids during extraction. Cell disruption was performed using a bead cell disruptor, with one cycle consisting of 30 seconds of disruption followed by 30 seconds of rest, for a total of 20 cycles (room temperature). The suspension after disruption was centrifuged (10,000 g, 5 min) and the supernatant was collected and subjected to HPLC analysis. ・Measurement of Phytoene Amount The HPLC conditions for phytoene were as follows. Instrument: Shimadzu PDA detector, Column: Inertsil ODS-3 column (5 μm, 150 mm × 4.6 mm, GL Sciences), Mobile phase: 50% methanol / 40% acetonitrile / 10% isopropyl alcohol, Flow rate: 1.0 mL / min, Column temperature: 45°C, Detection wavelength: 287 nm.
[0086] Figure 46 shows the phytoene production of the crtI gene-deficient strain (YTKA853). Phytoene production under conditions without CaCO3 addition was 9.3 mg / L. On the other hand, phytoene production under conditions with CaCO3 addition was 16.7 mg / L, indicating an approximately 80% increase in phytoene production with the addition of CaCO3. The addition of CaCO3 is thought to have adjusted the pH of the culture medium to a suitable range, maintaining a pH environment suitable for phytoene biosynthesis. Therefore, it was confirmed that the YTKA853 strain, in which the crtI gene is disrupted, can produce phytoene. The modified Corynebacterium strain described herein can be applied not only to the production of retinal but also to the production of other carotenoid compounds such as phytoene, which has UV-absorbing properties.
[0087] (Summary of Examples) The retinal synthesis method of this disclosure was compared with existing retinal production methods using microorganisms. Compared with previous studies using Escherichia coli, Yarrowia lipolytica, Saccharomyces cerevisiae, etc., the retinal synthesis method using coryneform bacteria of this disclosure is superior in the following respects: High purity of retinal (>99%): While other microorganisms produce mixtures of retinal, retinol, retinoic acid, retinyl acetate, etc., the production method of this disclosure can produce retinal in high purity. High yield (2,974 mg / L, organic phase): The synthesis method of this disclosure achieved a yield exceeding the highest value (2,094 mg / L) achieved when using S. cerevisiae. Use of an inexpensive carbon source: Unlike previous studies that used purified glucose or glycerol, inexpensive molasses can be used as a carbon source. Temperature optimization and use of two-phase culture: Two-phase culture using Corynebacterium, combined with optimization of culture temperature (21°C), achieved highly efficient and large-scale retinal production. Use of molasses as a carbon source and corn steep liquor as a nitrogen source: Although unexpected, no β-carotene production was detected, and the purity of retinal improved. Furthermore, the following additional findings were obtained in Examples 10-13. Improved retinal production due to high expression of the idsA gene (Example 10): The YTKA777 strain, which highly expressed the idsA gene encoding polyprenyl diphosphate synthase, produced approximately 42% more retinal than the parent strain (YTKA747 strain) (see Figure 35). This is due to the increased carbon flux to the GGPP synthesis pathway in coordination with the crtE gene due to high expression of the idsA gene, thereby improving the supply of retinal precursors (see Figures 32 and 33). Improved fructose utilization through high expression of ptsF / fruK genes (Example 11): YTKA813 strain, which highly expressed the ptsF gene encoding the fructose-specific phosphotransferase system (EIIBCFru) and the fruK gene encoding fructokinase, showed an additional retinal production of approximately 11% compared to the idsA gene-high expression strain (see Figure 37).A significant decrease in the amount of fructose remaining in the culture medium was observed, confirming improved carbon source utilization efficiency. Mass production using a jar fermenter (Example 11): In jar fermenter culture using strain YTKA813, 148.7 mg / L of retinal was produced based on the volume of the aqueous phase (2,974 mg / L based on the volume of the organic phase). This value exceeded the previously reported retinal production by Corynebacteria (104.9 mg / L based on the volume of the aqueous phase, Hao et al., Bioresour. Technol., 2026), achieving the highest value ever recorded for retinal production using Corynebacteria (see Figures 38, 39, and 40). Furthermore, no retinol or retinoic acid was detected by HPLC chromatogram, confirming high-purity retinal production. High-purity retinal production using corn steep liquor (Example 12): In the YTKA813 strain, when CSL + molasses medium was used, β-carotene accumulation was below the detection limit, reproducing the results of Example 9 (using YTKA747 strain) (see Figure 43). In other words, it was confirmed that the effect of suppressing β-carotene accumulation by using CSL as a nitrogen source is maintained even in modified strains with added idsA and ptsF / fruK genes. Phytoene production (Example 13): The YTKA853 strain, in which the crtI gene encoding phytoene desaturase in the carotenoid synthesis pathway was disrupted, selectively accumulated phytoene (see Figure 44). It produced 9.3 mg / L of phytoene under conditions without CaCO3 addition and 16.7 mg / L under conditions with CaCO3 addition, and an increase of approximately 80% in production was confirmed with the addition of CaCO3 (see Figure 46). In other words, the modified Corynebacterium of this disclosure is a highly versatile platform capable of selectively producing retinal, lycopene, and phytoene by controlling the carotenoid synthesis pathway (gene introduction, deletion, or expression level regulation).
[0088] Based on the above results, this disclosure can provide a method for synthesizing retinal and a retinal-producing host. Furthermore, this disclosure can provide a method for synthesizing lycopene. In addition, this disclosure can provide a method for synthesizing phytoene and a phytoene-producing host. The modified Corynebacterium of this disclosure can be mass-cultured using inexpensive raw materials (molasses and corn steep liquor) and can be used for the industrial production of retinal, lycopene, and phytoene in fields such as food, cosmetics, pharmaceuticals, and animal feed.
Claims
1. A method for synthesizing lycopene or retinal, the synthesis method comprising culturing a modified host having the EMP pathway, the MEP pathway and the carotenoid biosynthesis pathway, and having increased expression levels of a gene encoding at least one enzyme of the carotenoid biosynthesis pathway, in a culture medium, and recovering lycopene or retinal from the culture obtained by the culture.
2. The method according to claim 1, wherein the modified host has been introduced with or has a gene encoding lycopene cyclase and a gene encoding β-carotene 15,15'-dioxygenase, and the recovery is the recovery of retinal.
3. The method according to claim 2, wherein the enzymatic activity of glyceraldehyde-3-phosphate dehydrogenase in the EMP pathway is reduced.
4. The method according to claim 3, wherein a mutation is introduced in the start codon of the gene encoding glyceraldehyde-3-phosphate dehydrogenase.
5. The method according to claim 2, wherein the host gene encoding lycopene elongation enzyme (crtEb) is substantially deleted, absent, or non-functional.
6. The method according to claim 2, wherein the gene encoding a host carotenoid biosynthesis regulator (crtR gene) is substantially deleted or absent.
7. The method according to claim 2, wherein a gene encoding GGPP synthase, a gene encoding phytoene synthase, and / or a gene encoding phytoene desaturase of the host is introduced or the expression level of said genes is increased.
8. The method according to claim 2, wherein the host gene encoding DXS, the gene encoding DXR, the gene encoding IspE, the gene encoding IspG, the gene encoding IspH and / or the gene encoding Idi is introduced or the expression level of said gene is increased.
9. The method according to claim 2, wherein the culture medium contains iron ions.
10. The method according to claim 2, wherein the culture includes a two-phase culture step.
11. The method according to claim 10, wherein the culture medium in the two-phase culture stage contains an antioxidant.
12. The method according to claim 10, wherein the culture temperature of the two-phase culture is 16°C to 23°C.
13. The method according to claim 2, wherein the culture is cultured in a culture medium containing molasses.
14. The method according to claim 13, wherein the culture medium containing molasses is not supplemented with purified sucrose, biotin, and thiamine.
15. The method according to claim 2, wherein the culture is cultured in a culture medium containing corn steep liquor.
16. The method according to claim 2, wherein the culture is cultured in a culture medium containing molasses and corn steep liquor.
17. The method according to claim 16, wherein the culture medium containing molasses and corn steep liquor is not supplemented with purified sucrose, biotin, and thiamine.
18. The method according to claim 2, wherein the host is a Corynebacterium.
19. The method according to claim 2, wherein the enzymatic activity of glyceraldehyde-3-phosphate dehydrogenase in the EMP pathway is reduced, the gene encoding the host lycopene elongation enzyme is substantially deleted or absent, the gene encoding the host carotenoid biosynthesis regulator is substantially deleted or absent, the gene encoding the host GGPP synthase, the gene encoding phytoene synthase and / or phytoene desaturase is introduced or its expression level is increased, and the gene encoding the host DXS, the gene encoding DXR, the gene encoding IspE, the gene encoding IspG, the gene encoding IspH and / or Idi is introduced or its expression level is increased.
20. The method according to claim 2, wherein the host gene encoding polyprenyl diphosphate synthase (idsA gene) is introduced or the expression level of the gene is increased.
21. The method according to claim 2, wherein a gene encoding the EIIBCFru component of the host fructose-specific phosphotransferase system (ptsF gene) and a gene encoding fructokinase (fruK gene) are introduced or the expression levels of said genes are increased.
22. The method according to claim 21, wherein the culture comprises a main culture step of culturing in a medium containing molasses and corn steep liquor, and the β-carotene content in the recovered retinal is below the detection limit.
23. The method according to claim 21, wherein the culture includes a culture step using a jar fermenter.
24. The method according to claim 1, wherein the recovery is the recovery of lycopene, and the modified host does not have a gene encoding lycopene cyclase (crtY gene) introduced or is not functional.
25. The method according to claim 24, wherein the enzymatic activity of glyceraldehyde-3-phosphate dehydrogenase in the EMP pathway is reduced.
26. The method according to claim 25, wherein a mutation is introduced in the start codon of the gene encoding glyceraldehyde-3-phosphate dehydrogenase.
27. The method according to claim 24, wherein the host gene encoding lycopene elongation enzyme (crtEb) is substantially deleted, absent, or non-functional.
28. The method according to claim 24, wherein the host gene encoding GGPP synthase, the gene encoding phytoene synthase and / or the gene encoding phytoene desaturase is introduced or the expression level of said gene is increased, and the host gene encoding DXS, the gene encoding DXR, the gene encoding IspE, the gene encoding IspG, the gene encoding IspH and / or the gene encoding Idi is introduced or the expression level of said gene is increased.
29. The method according to claim 24, wherein the host is a Corynebacterium.
30. A method for synthesizing phytoene, comprising culturing a modified host having the EMP pathway, the MEP pathway, and the carotenoid biosynthesis pathway, and having a substantially deleted or non-functional gene encoding phytoene desaturase (crtI gene), in a culture medium, and recovering phytoene from the culture obtained by the culture.
31. The method according to claim 30, wherein the culture medium contains calcium carbonate.
32. The method according to claim 30, wherein the host is a Corynebacterium.
33. A retinal-producing host, the host having or having introduced genes encoding lycopene cyclase and β-carotene 15,15'-dioxygenase, and possessing the EMP pathway, MEP pathway and carotenoid biosynthesis pathway, and having reduced enzymatic activity of glyceraldehyde-3-phosphate dehydrogenase in the EMP pathway.
34. The host according to claim 33, wherein a mutation has been introduced into the start codon of the gene encoding glyceraldehyde-3-phosphate dehydrogenase.
35. The host according to claim 33, wherein the gene encoding the lycopene elongation enzyme is absent or substantially deleted.
36. The host according to claim 33, wherein the host has substantially no genes encoding carotenoid biosynthesis regulators or no genes at all.
37. The host according to claim 33, wherein a gene encoding GGPP synthase, a gene encoding phytoene synthase, and / or a gene encoding phytoene desaturase have been introduced into the host or the expression level of said genes has been increased.
38. The host according to claim 33, wherein the host has been introduced with or has increased expression levels of the genes encoding DXS, DXR, IspE, IspG, IsppH and / or Idi.
39. The host according to claim 33, wherein the host has been introduced with a gene encoding polyprenyl diphosphate synthase (idsA gene) or the expression level of said gene has been increased.
40. The host according to claim 33 or 39, wherein a gene encoding the EIIBCFru component of the host's fructose-specific phosphotransferase system (ptsF gene) and a gene encoding fructokinase (fruK gene) have been introduced or the expression levels of said genes have been increased.
41. A phytoene-producing host having the EMP pathway, the MEP pathway, and the carotenoid biosynthesis pathway, and having a substantially deleted or non-functional gene encoding phytoene desaturase (crtI gene).
